Overview

Randomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmentation and Lentigos

Status:
Recruiting

Trial end date:
2023-05-31

Target enrollment:

Participant gender:

Summary

This is a randomized, observer-blinded, vehicle-controlled multi-dose trial that examines the effect of twice daily application of 0.8% DBI-102 Gel, 4% Hydroquinone cream, and Vehicle Gel for 12 weeks in adults with Fitzpatrick Skin Types IV-V and a colorimeter L* measurement between 57.8 and 46.1.

Phase:

Phase 2

Details

Lead Sponsor:

DermBiont, Inc.

Treatments:

Hydroquinone